Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor: dansylarginine N-(3-ethyl-1, 5-pentanediyl)amide. - Suppr | 超能文献

Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor: dansylarginine N-(3-ethyl-1, 5-pentanediyl)amide.

作者信息

Pearlstein E, Ambrogio C, Gasic G, Karpatkin S

出版信息

Prog Clin Biol Res. 1982;89:479-502.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor: dansylarginine N-(3-ethyl-1, 5-pentanediyl)amide.

Prog Clin Biol Res. 1982;89:479-502.

2

Inhibition of the platelet-aggregating activity of two human adenocarcinomas of the colon and an anaplastic murine tumor with a specific thrombin inhibitor, dansylarginine N-(3-ethyl-1,5-pentanediyl)amide.

Cancer Res. 1981 Nov;41(11 Pt 1):4535-9.

3

Identification of a platelet-aggregating factor of murine colon adenocarcinoma 26: Mr 44,000 membrane protein as determined by monoclonal antibodies.

Cancer Res. 1988 Nov 15;48(22):6411-6.

4

Differentiation of platelet-aggregating effects of human tumor cell lines based on inhibition studies with apyrase, hirudin, and phospholipase.

Cancer Res. 1982 Nov;42(11):4348-52.

5

Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amide.

Biochemistry. 1979 Mar 20;18(6):996-1003. doi: 10.1021/bi00573a010.

6

Aggregation of human platelets in plasma by porcine blood cells in vitro is probably mediated by thrombin generation.

Xenotransplantation. 2003 Sep;10(5):454-9. doi: 10.1034/j.1399-3089.2003.00061.x.

7

Platelet aggregating material (PAM) of two virally-transformed tumors: SV3T3 mouse fibroblast and PW20 rat renal sarcoma. Role of cell surface sialylation.

Prog Clin Biol Res. 1982;89:445-77.

8

Study of platelet aggregation in vivo. IX. Effect of nafazatrom on in vivo platelet aggregation and spontaneous tumor metastasis.

J Med. 1982;13(1-2):35-47.

9

Purification and characterization of the platelet-aggregating sialoglycoprotein gp44 expressed by highly metastatic variant cells of mouse colon adenocarcinoma 26.

Cancer Res. 1995 Feb 15;55(4):767-73.

10

Characterization of the platelet-aggregating activity of tumor cells.

Cancer Res. 1980 Apr;40(4):1217-22.

引用本文的文献

1

Direct Oral Anticoagulant Drugs: On the Treatment of Cancer-Related Venous Thromboembolism and their Potential Anti-Neoplastic Effect.

Cancers (Basel). 2019 Jan 5;11(1):46. doi: 10.3390/cancers11010046.

2

Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?

Cancer Metastasis Rev. 2017 Jun;36(2):305-329. doi: 10.1007/s10555-017-9683-z.